Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistIndulgeRx Brands, Inc was cited for marketing three nut butter products (Bravezil Butter, Inspiration Butter, and Wellnut Butter) as unapproved drugs rather than conventional foods. The company made disease claims on its website stating the products could fight cancer and assist in treating certain diseases through their antioxidant and nutrient content, which violated the Federal Food, Drug, and Cosmetic Act by establishing drug intent without FDA approval. The products were being sold through the company's website (fightbackfoods.com) and introduced into interstate commerce without the required new drug applications or marketing authorizations.